Experience

Tevard Biosciences

• United States
• Biotechnology
• 1 - 100 Employee

• Associate Director, Novel Platform

  • Mar 2023 - Nov 2023

  Cambridge, Massachusetts, United States Led a cross-functional team comprising senior scientists and research associates to execute Proof of Concept initiatives in cutting-edge technology and innovative therapeutics grounded in tRNA and mRNA biology.



Carbon Biosciences

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist, Translational Biology

  • Jul 2022 - Mar 2023

  Greater Boston Scientific lead in conducting Proof of Concept study using non-AAV virus for Cystic Fibrosis gene therapy.



LogicBio Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist, pre-clinical Pharmacology

  • Jan 2022 - Jun 2022

  Program Lead, Gene Therapy (AAV, liver genetic disorder).

• Senior Scientist

  • Nov 2020 - Dec 2021

  Conducted pre-clinical pharmacology and IND-enabling studies for a liver genetic disorder using in vivo genome editing technology (precision large gene insertion). Scientific lead in the advancement of best-in-class genome editing technology for precise large gene insertion.



Sanofi

• France
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Scientist, Rare Blood Disorder

  • Sep 2018 - Aug 2020

  Waltham, MA Scientific support the development of BIVV001, an FDA-approved engineered Factor VIII with extended half-life. Scientific support the development of Fitusiran (LNP-siRNA targeting antithrombin). Scientific lead a new biological target validation for Rare blood disorder.



RTI International

• United States
• Research Services
• 700 & Above Employee

• Postdoctoral Pharmacologist

  • Sep 2017 - Sep 2018

  Research Triangle Park, North Carolina U.S.A.



University of North Carolina at Chapel Hill

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Fellow

  • Feb 2012 - Aug 2017

  Chaple Hill, North Carolina USA